Menu Search
Equities

Zinzino AB

  • Add to watchlist
  • Add to portfolio
  • Add an alert
9EE:MUN

Zinzino AB

Actions
  • Price (EUR)12.32
  • Today's Change0.00 / 0.00%
  • Shares traded150.00
  • 1 Year change+0.33%
  • Beta0.9174
Data delayed at least 15 minutes, as of Feb 16 2026 07:01 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Zinzino AB is a Sweden-based global Company engaged in selling dietary supplements, skin care and lifestyle products. The Company specializes in biomarker-based, personalized nutrition and health tech. The Company’s test-based, scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino AB owns the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The Company’s headquarter is in Gothenburg, Sweden with additional offices in Finland, Latvia, Norway, USA, Australia, Hong Kong, Malaysia and India.

  • Revenue in SEK (TTM)2.86bn
  • Net income in SEK243.96m
  • Incorporated2007
  • Employees294.00
  • Location
    Zinzino ABHulda Mellgrens gata 5VAESTRA FROELUNDA 421 32SwedenSWE
  • Phone+46 3177171
  • Fax+46 317269976
  • Websitehttps://www.zinzino.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		ZZ B:STO since
announced		Transaction
value
IT WORKS Marketing IncDeal completed26 Jan 202626 Jan 2026Deal completed-9.71%33.76m
Undisclosed Peruvian SubsidiaryAnnounced08 Nov 202508 Nov 2025Announced13.02%--
Undisclosed Colombian SubsidiaryAnnounced08 Nov 202508 Nov 2025Announced13.02%--
S&M Nano-Biotechnology SA de CV-Business AssetsAnnounced08 Nov 202508 Nov 2025Announced13.02%20.00m
Truvy Korea Co LLCDeal completed25 Sep 202525 Sep 2025Deal completed-14.90%--
Data delayed at least 15 minutes, as of Feb 16 2026 11:01 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.